Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Influence of cytochrome P450 2C19 genetic polymorphism on H. pylori eradication therapy].

Nihon rinsho. Japanese journal of clinical medicine - 1 Nov 2005

Hikichi Takuto, Irisawa Atsushi, Abe Chikako, Obara Katsutoshi, Sato Yukio

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amoxicillin
Share to Clarithromycin
Share to Cytochrome P-450 CYP2C19
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Metronidazole

Share to Mixed Function Oxygenases

Share to Omeprazole

Share to Proton Pump Inhibitors

Source

Identifiers

PMID: 16363603

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Influence of cytochrome P450 2C19 genetic polymorphism on H. pylori eradication therapy].PMID 16363603Read ↗

[Effect of CYP2C19 gene polymorphism on eradication treatment efficacy of Helicobacter pylori infection].Semantic proximity Read ↗

[Cytochrome-P-4502C19 gene polymorphism and Helicobacter pylori infection treatment].Semantic proximity Read ↗

CYP2C19 polymorphism influences Helicobacter pylori eradication.Semantic proximity Read ↗

[The relationship between genetic polymorphism of CYP2C19 and the efficacy of Helicobacter pylori eradication therapy in children].Semantic proximity Read ↗

Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication.Semantic proximity Read ↗

Therapeutic impact of CYP2C19 pharmacogenetics on proton pump inhibitor-based eradication therapy for Helicobacter pylori.Semantic proximity Read ↗

[Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy].Semantic proximity Read ↗

Influence of CYP2C19 on Helicobacter pylori eradication in Brazilian patients with functional dyspepsia.Semantic proximity Read ↗

Effects of CYP2C19 loss-of-function variants on the eradication of H. pylori infection in patients treated with proton pump inhibitor-based triple therapy regimens: a meta-analysis of randomized clinical trials.Semantic proximity Read ↗

CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection.Semantic proximity Read ↗

Polymorphisms in the host CYP2C19 gene and antibiotic-resistance attributes ofHelicobacter pyloriisolates influence the outcome of triple therapySemantic proximity Read ↗

[Effectiveness of eradication regimen based on the bacterial susceptibility and CYP2C19 genotype in children with refractory Helicobacter pylori infection].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.